Shanghai, Shanghai
Disclosures:
2688 - Locoregional Recurrence and Survival Outcome of HER2-Low Breast Cancer Patients after Upfront Surgery and Adjuvant Radiotherapy
Monday, September 30, 20243:00 PM – 4:00 PM ET